FrieslandCampina Research and Development
Wageningen, 6708 WH, Netherlands
NCT Number: NCT05372601
In modern life, many people state to experience stress. Women compared to men report more and higher levels of stress. Recent research found that supplementation of galactose-oligosaccharides (GOS) resulted in reduced anxiety levels in British female students with higher anxiety scores at baseline in self-reported trait anxiety. Moreover, supplementation of probiotics in germ-free rodents resulted in reduced levels of circulating corticosterone (cortisol in humans). These findings illustrate the potential of prebiotic supplementation, through the microbiota-gut-brain (MGB) axis, to improve mental health and wellbeing.
The present study aims to study the effect of oligosaccharides on self-perceived stress.
Looking for future studies?
Notify Me25 year–45 year
Female
Interventional
Not applicable
Wageningen, 6708 WH, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Prebiotics, daily administered
Placebo, daily administered
Time frame: 28 days
The difference in absolute stress sub-score after the product intervention between the product groups (using the Depression Anxiety Stress Scale (DASS-42)), in which a lower score corresponds with a lower stress level
FrieslandCampina
Industry
The Effect of Galacto-oligosaccharides (GOS) on Self-perceived Stress in Apparently Healthy But Stressed Dutch Women: Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731464
Anxiety, Anxiety Disorders
Islamabad, Federal, Pakistan
View Trial DetailsNCT07255365
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02257853
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT06085105
Adverse Outcomes, Behavior
Navrongo, Ghana
View Trial Details